MedPath

MYLAN-WARFARIN

MYLAN-WARFARIN

Discontinued
DIN Number

02287498

Drug Class

Human

Market Date

Oct 21, 2006

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02287498
AIG Number0104597007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AA03 WARFARIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

WARFARIN SODIUMActive
Strength: 3 MG
Monograph: WARFARIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.